BALLERUP, Denmark - Friday, 21. October 2022
Adtralza, a biologic that targets and neutralizes the interleukin (IL)-13 cytokine1, is now approved in Europe for adolescents with moderate-to-severe atopic dermatitis.2
(BUSINESS WIRE) -- NOT FOR DISTRIBUTION IN THE UK OR IRELAND
LEO Pharma A/S, a global leader in medical dermatology, today announced that the European Commission (EC) has extended the marketing authorization for Adtralza® (tralokinumab) to include adolescents aged 12 to 17 with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.
“Safety is a priority when selecting a treatment option for adolescents living with moderate-to-severe atopic dermatitis, as it can be a chronic and life-long condition,” said Dr. Andreas Wollenberg, dermatologist, allergist, and Professor in the Department of Dermatology and Allergy, Ludwig-Maximilian University of Munich, Germany, and ECZTRA 6 clinical trial inve
...
Read more »
|
BALLERUP, Denmark - Friday, 21. October 2022
Adtralza, a biologic that targets and neutralizes the interleukin (IL)-13 cytokine1, is now approved in Europe for adolescents with moderate-to-severe atopic dermatitis.2
(BUSINESS WIRE) -- NOT FOR DISTRIBUTION IN THE UK OR IRELAND
LEO Pharma A/S, a global leader in medical dermatology, today announced that the European Commission (EC) has extended the marketing authorization for Adtralza® (tralokinumab) to include adolescents aged 12 to 17 with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.
“Safety is a priority when selecting a treatment option for adolescents living with moderate-to-severe atopic dermatitis, as it can be a chronic and life-long condition,” said Dr. Andreas Wollenberg, dermatologist, allergist, and Professor in the Department of Dermatology and Allergy, Ludwig-Maximilian University of Munich, Germany, and ECZTRA 6 clinical trial inve
...
Read more »
|
SYDNEY & AUCKLAND, New Zealand - Thursday, 20. October 2022
Australian leading electrical and maintenance services company able to refocus budget and its IT resources to enhance its digital transformation initiatives
(BUSINESS WIRE) -- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products, and a Salesforce partner, today announced that Southern Cross Electrical Engineering (SCEE) has switched to Rimini Street for support of its Oracle applications. The agreement enables SCEE to better maintain its Oracle applications during a business expansion and amidst an industry wide IT skills shortage.
In addition, the support from Rimini Street means SCEE has freed up budget and IT resources to focus on innovation and transformation projects which improve the efficiency and competitiveness of the entire organization.
“An investme
...
Read more »
|
(BUSINESS WIRE) -- On 18th October, the vape giant VOOPOO, which is famous for its popular DRAG product, officially released its latest Pod, ARGUS P1 on its website. ARGUS P1 is featured with the 15W PD fast charging and futuristic mechanical design, which will refresh your impression toward POD E-cigarette!
15W PD Lightening Charging Effectively Shortens Charging Time
ARGUS P1, with a built-in 800mAh battery and supporting USB-PD charging adapter, is equipped with 15W PD fast charging, which charges the battery from 0 to 80% within 12 minutes. It only takes one cup of coffee time to charge from 0 to 100%. It is the vape that keeps you away from the anxiety for battery life.
Futuristic Mechanical Design Reflects the Collection-level Craftsmanship
ARGUS P1 demonstrates a futuristic and mechanical style in a half-metal, half-transparent design. Each finish of the five different colors brings users a unique experience. Made with tough zinc alloy, with th
...
Read more »
|
(BUSINESS WIRE) -- Trueman Man Clinic Network announced that it has performed more than 25,700 gynecomastia operations as of September 2022 from 2010. Trueman Man Clinic Network is a renowned hospital for male-specific diseases, running nine clinics.
According to the Korean Health Insurance Review & Assessment Service and statistics of Healthcare Big Data, Trueman Man Clinic Network performed over 40 percent of gynecomastia surgeries in Korea over two years in 2020 and 2021.
The clinic’s reoperation rate is also as low as 0.25 percent. Out of 4,820 gynecomastia operations performed by the nine clinics in 2021, only twelve cases required reopera
...
Read more »
| |